Global Injectable Anticoagulants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
Market Analysis and Insights: Global Injectable Anticoagulants Market
In 2019, the global Injectable Anticoagulants market size was US$ 5814.9 million and it is expected to reach US$ 7070.3 million by the end of 2026, with a CAGR of 2.8% during 2021-2026.
Global Injectable Anticoagulants Scope and Market Size
Injectable Anticoagulants market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Injectable Anticoagulants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.
Segment by Type, the Injectable Anticoagulants market is segmented into
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
Segment by Application, the Injectable Anticoagulants market is segmented into
VTE
ACS/MI
AF
Other
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Injectable Anticoagulants market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Injectable Anticoagulants product introduction, recent developments, Injectable Anticoagulants sales by region, type, application and by sales channel.
The major companies include:
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
...
In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
Market Analysis and Insights: Global Injectable Anticoagulants Market
In 2019, the global Injectable Anticoagulants market size was US$ 5814.9 million and it is expected to reach US$ 7070.3 million by the end of 2026, with a CAGR of 2.8% during 2021-2026.
Global Injectable Anticoagulants Scope and Market Size
Injectable Anticoagulants market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Injectable Anticoagulants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.
Segment by Type, the Injectable Anticoagulants market is segmented into
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
Segment by Application, the Injectable Anticoagulants market is segmented into
VTE
ACS/MI
AF
Other
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
and Injectable Anticoagulants Market Share AnalysisInjectable Anticoagulants market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Injectable Anticoagulants product introduction, recent developments, Injectable Anticoagulants sales by region, type, application and by sales channel.
The major companies include:
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
...
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
